PK 44 phosphate is an indole and indazole-based structure belonging to DPP-IV inhibitor type of effect (IC50 = 15.8 nM) reported by Tozer96 in the treatment of type 2 diabetes mellitus. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.